SERB - About the company
SERB is an unfunded company based in Brussels (Belgium), founded in 1950. It operates as a R&D company focused on manufacturing specialty drugs for multiple therapeutic areas. SERB has not raised any funding yet.
Company Details
- Website
- serb.com
- Social
Legal entities associated with SERB
SERB is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
SERB CIN: 0538.813.719 , Belgium, Active | Sep 19, 2013 | $99.6M (As on Dec 31, 2024) | 9 (As on Dec 31, 2022) | - |
Sign up to download SERB's company profile
SERB's funding and investors
SERB has not raised any funding rounds yet. SERB has 1 institutional investor.
View details of SERB's funding rounds and investors
SERB's founders and board of directors
Founder? Claim ProfileSERB's employee count trend
SERB has 9 employees as of Dec 22. The total employee count is 13.0% more than what it was in Dec 21. Here is SERB's employee count trend over the years:
Uncover SERB's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
SERB's Investments and acquisitions
SERB has acquired 3 companies including Y-mAbs Therapeutics, VISTOGARD® and Xuriden. SERB has not made any investments as of now.Here is the list of its acquisitions:
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Aug 05, 2025 | Acquisition | 2014 | New York City (United States) | |
Jul 13, 2023 | Acquisition | 2011 | Rockville (United States) | |
Jul 13, 2023 | Acquisition | 2011 | Rockville (United States) |
Want to know more about where corporates are investing? Sign up today!See all acquisitions by SERB
News related to SERB
Filter this listMedia has covered SERB for a total of 7 events in the last 1 year, 1 of them has been about partnerships and 1 about people movement.
•
•
Dr. Vignesh Rajah Appointed as SERB Pharmaceuticals’ Chief Medical OfficerGlobeNewswire•Nov 17, 2025•SERB
•
SERB Pharmaceuticals Completes Acquisition of Y-mAbs TherapeuticsGlobeNewswire•Sep 16, 2025•SERB, Y-mAbs Therapeutics
•
SERB Pharmaceuticals to Acquire Y-mAbs TherapeuticsForexTV•Aug 05, 2025•SERB, Y-mAbs Therapeutics, Monteverde, DistributionNOW and 2 others
•
•
First FDA-approved treatment for severe frostbite now commercially available in the USGlobeNewswire•Dec 09, 2024•SERB
•
•
FDA gives SFJ and SERB’s bentracimab BLA priority reviewPharmaceutical Technology•Aug 05, 2024•SFJ Pharmaceuticals, SERB
•
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about SERB
Explore our recently published companies
- 5Gtech - 2020 founded, Public company
- Effecta Gmbh - Unfunded company
- Tapico - 2018 founded, Unfunded company
- Alessandromoro - Unfunded company
- Dawninsight - 2018 founded, Unfunded company
- Zspcapital - 2018 founded, Unfunded company
